HAPPINESS BIOTECH GROUP LTD (HAPP): Price and Financial Metrics


HAPPINESS BIOTECH GROUP LTD (HAPP): $0.88

0.00 (0.15%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

HAPP POWR Grades


  • Value is the dimension where HAPP ranks best; there it ranks ahead of 96.5% of US stocks.
  • HAPP's strongest trending metric is Value; it's been moving up over the last 51 weeks.
  • HAPP's current lowest rank is in the Quality metric (where it is better than 6.23% of US stocks).

HAPP Stock Summary

  • Happiness Biotech Group Ltd's market capitalization of $28,118,662 is ahead of merely 3.68% of US-listed equities.
  • HAPP's went public 1.98 years ago, making it older than only 3.4% of listed US stocks we're tracking.
  • HAPP's price/sales ratio is 0.39; that's higher than the P/S ratio of only 6.86% of US stocks.
  • Stocks that are quantitatively similar to HAPP, based on their financial statements, market capitalization, and price volatility, are OFLX, NEOG, ARTW, MSON, and MYGN.
  • HAPP's SEC filings can be seen here. And to visit Happiness Biotech Group Ltd's official web site, go to www.happ.org.cn.

HAPP Valuation Summary

  • HAPP's price/sales ratio is 0.5; this is 86.84% lower than that of the median Healthcare stock.
  • Over the past 23 months, HAPP's price/earnings ratio has gone up 39.2.
  • Over the past 23 months, HAPP's EV/EBIT ratio has gone down 3.7.

Below are key valuation metrics over time for HAPP.

Stock Date P/S P/B P/E EV/EBIT
HAPP 2021-08-31 0.5 0.4 44.7 0.4
HAPP 2021-08-30 0.5 0.4 43.9 0.1
HAPP 2021-08-27 0.5 0.4 44.3 0.3
HAPP 2021-08-26 0.5 0.4 43.1 -0.2
HAPP 2021-08-25 0.5 0.4 45.3 0.7
HAPP 2021-08-24 0.5 0.4 45.9 1.0

HAPP's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • HAPP has a Quality Grade of D, ranking ahead of 6.08% of graded US stocks.
  • HAPP's asset turnover comes in at 0.723 -- ranking 37th of 681 Pharmaceutical Products stocks.
  • 500 - Internal server error

The table below shows HAPP's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-03-31 0.723 0.254 0.034
2020-09-30 0.674 0.435 0.216
2020-03-31 0.863 0.468 0.334
2019-03-31 1.074 0.504 0.532

HAPP Price Target

For more insight on analysts targets of HAPP, see our HAPP price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $3.00 Average Broker Recommendation 1.5 (Moderate Buy)

HAPP Stock Price Chart Interactive Chart >

Price chart for HAPP

HAPP Price/Volume Stats

Current price $0.88 52-week high $2.58
Prev. close $0.88 52-week low $0.81
Day low $0.86 Volume 31,500
Day high $0.90 Avg. volume 674,332
50-day MA $1.05 Dividend yield N/A
200-day MA $1.63 Market Cap 28.16M

HAPPINESS BIOTECH GROUP LTD (HAPP) Company Bio


Happiness Biotech Group Ltd. is a nutraceutical and dietary supplements producer, which engages in the research, development, manufacturing, marketing, and sales of a variety of products made from herbal and animal extracts. The firm's products include lucidum spore powder; cordyceps mycelia; ijiao solution; and American ginseng. It operates under the brand name Happiness. The company was founded on February 9, 2018 and is headquartered in Nanping City, China.


HAPP Latest News Stream


Event/Time News Detail
Loading, please wait...

HAPP Latest Social Stream


Loading social stream, please wait...

View Full HAPP Social Stream

Latest HAPP News From Around the Web

Below are the latest news stories about Happiness Biotech Group Ltd that investors may wish to consider to help them evaluate HAPP as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Good morning, investor!

William White on InvestorPlace | September 29, 2021

Happiness Biotech Enters $14M Electric Vehicle Transaction With Ruili

Happiness Biotech Group Ltd (NASDAQ: HAPP) announced that Taochejun (Fujian) Automobile Distribution Co Ltd and its subsidiary had signed agreements with Guang'an Ruili Trading Co Ltd (Ruili) to purchase 1350 of the model Bestune B30 EV 400. The value of the order is about $14.7 million. Besturn is an automotive marque owned by the Chinese automaker FAW Group. "We have obtained pre-sale orders for most of the 1350 electric vehicles, and we are confident that the sales will be completed in a shor

Yahoo | September 23, 2021

Happiness Biotech Announced Another Electric Vehicle Transaction of Over $14 Million With Ruili

Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), a China-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce solutions, and the sales of automobile, today announced that Taochejun (Fujian) Automobile Distribution Co., Ltd. ("Taochejun") and its subsidiary have signed agreements with Guang'an Ruili Trading Co., Ltd ("Ruili") to purchase 1350 of the model Bestune B30 EV 400.

Yahoo | September 23, 2021

Happiness Biotech Announced The Launch of Its Lucidum Tablets on DouYin Mall

Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer and e-commerce services provider, today announced one of its nutraceutical products - Lucidum Tablets, have been launched for sale on the DouYin Mall, a virtual mall built within a Douyin mini-program.

Yahoo | September 10, 2021

Happiness Biotech Announced Financial Results for Fiscal Year Ended March 31, 2021

Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer and e-commerce services provider, today announced its financial results for the fiscal year ended March 31, 2021.

Yahoo | August 2, 2021

Read More 'HAPP' Stories Here

HAPP Price Returns

1-mo -18.52%
3-mo -39.73%
6-mo -49.13%
1-year -49.71%
3-year N/A
5-year N/A
YTD -52.17%
2020 -59.60%
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9048 seconds.